aid: castle-creek-biosciences

name: Castle Creek Biosciences

image: http://castlecreekbio.com/wp-content/uploads/2020/03/CCB-Logo-500x500-1.png

description: 'Castle Creek Biosciences is a late‑stage biotechnology company developing autologous fibroblast‑based gene therapies for rare genetic skin disorders such as dystrophic epidermolysis bullosa. The firm conducts a registrational trial of its lead candidate D‑Fi and aims to create transformative, personalized treatments for patients with severe genetic diseases. It operates from Exton, Pennsylvania, and focuses on both ex vivo and in vivo approaches to deliver durable therapeutic outcomes.'

url: https://raw.githubusercontent.com/api-evangelist/castle-creek-biosciences/refs/heads/main/apis.yml

x-type: company

x-source: harvest:secondary-market

x-tier: profiled
x-tier-reason: enrichment pass 2026-10-07 (modular-v1; was harvest)

specificationVersion: '0.20'

created: '2026-10-07'

modified: '2026-10-07'

tags:
- Biotechnology
- Gene Therapy
- Regenerative Medicine
- Healthcare
- Biotech Company

maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io

common:
- type: SecurityTxt
  url: well-known/castle-creek-biosciences-clarity-security.txt
- type: WellKnown
  url: well-known/castle-creek-biosciences-well-known.yml
- type: Security
  url: https://clarity.com/vdp
- type: Hosts
  url: hosts/castle-creek-biosciences-hosts.yml
- type: Vendors
  url: vendors/castle-creek-biosciences-vendors.yml
- type: Leadership
  url: https://castlecreekbio.com/about/leadership/
- type: VulnerabilityDisclosure
  url: security/castle-creek-biosciences-vulnerability-disclosure.yml
- type: DomainSecurity
  url: security/castle-creek-biosciences-domain-security.yml
- type: Website
  url: https://castlecreekbio.com
- type: Documentation
  url: https://castlecreekbio.com/technology/
- type: PrivacyPolicy
  url: https://castlecreekbio.com/privacy-policy
- type: TermsOfService
  url: https://castlecreekbio.com/terms-of-use

apis: []

x-coverage:
  state: none
  reason: no-developer-program
  method: derived
  generated: '2026-10-07'
  generator: derive-coverage.py (pre-flight evidence)
  detail: >-
    the company publishes no developer documentation host and no machine-readable contract on its own domain
  evidence:
  - url: https://castlecreekbio.com
    status: 200
  - url: https://www.hiive.com/securities/castle-creek-biosciences-stock
    status: 200
x-enrichment:
  date: '2026-10-07'
  status: enriched
  artifacts_added: 7
  pass: modular-v1
  engine: identity=local,contract=local,surfaces=local,docs=local,regulatory=local